Search Results

You are looking at 1 - 10 of 51 items for :

  • nodular thyroid disease x
  • Refine by Access: All content x
Clear All
Open access

Irfan Vardarli, Manuel Weber, Frank Weidemann, Dagmar Führer, Ken Herrmann, and Rainer Görges

and corresponds to 1–3% of all histologically proven thyroid cancers in the United States, with a prevalence of 0.1–1.4% in patients with nodular thyroid disease ( 2 , 4 ), appearing either sporadically or in a hereditary form as a component of the

Open access

Marek Niedziela

foetal/neonatal hyperthyroidism of maternal origin and the hyperthyroid phase of AIT). It is sometimes caused by less frequent non-autoimmune diseases of the thyroid gland (nodular toxic goitre, germline gain-of-function mutation of the TSH receptor or Gs

Open access

C Sui, Q He, R Du, D Zhang, F Li, G Dionigi, N Liang, and H Sun

.1%. Multifocality (OR = 1.443, 95%CI: 1.289–1.615) and thyroiditis (OR = 1.197, 95%CI: 1.034–1.410) increased the risk of stage N1b disease. Capsular infiltration (OR = 0.820, 95%CI: 0.713–0.944) and nodular goiter (OR = 0.839, 95%CI: 0.732–0.962) decreased the risk

Open access

Kristine Zøylner Swan, Steen Joop Bonnema, Marie Louise Jespersen, and Viveque Egsgaard Nielsen

Introduction Thyroid nodular disease is common in many populations, with the majority of the nodules being benign ( 1 ). The primary purpose of diagnostic testing is to assess the risk of thyroid carcinoma in these nodules. Although

Open access

Suvanjaa Sivalingam, Marianne Thvilum, Thomas Heiberg Brix, Laszlo Hegedüs, and Frans Brandt

Introduction Hyperthyroidism is a common condition with a lifetime risk of 2–10% ( 1 , 2 ). Graves’ disease (GD) and toxic nodular goitre (TNG) are the most frequent causes of hyperthyroidism ( 2 ). GD is an organ specific autoimmune disease

Open access

Paolo G Arduino, Dora Karimi, Federico Tirone, Veronica Sciannameo, Fulvio Ricceri, Marco Cabras, Alessio Gambino, Davide Conrotto, Stefano Salzano, Mario Carbone, and Roberto Broccoletti

Normal 303 (98.7%) 241 (99.6%) Low 4 (1.3%) 0 (0%) Elevated 0 (0%) 1 (0.4%)   P -value = 0.08 Thyroid disease positive patients No. 71 (/307) No. 22 (/242) Nodular thyroid diseases 9 (12.7%) 3 (13

Open access

Ling Hu, Ting Li, Xiao-Ling Yin, and Yi Zou

-6999.20140246 ) 11 Fiore E Vitti P . Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease . Journal of Clinical Endocrinology and Metabolism 2012 97 1134 – 11 45. ( ) 12 Qiu L . Study on

Open access

John E M Midgley, Rolf Larisch, Johannes W Dietrich, and Rudolf Hoermann

, autoimmune thyroiditis; Goitre, goitre post surgery for benign nodular thyroid disease. Median thyroid volume was 0 ml (IQR 0, 0 ml) in carcinomas, 7 ml (IQR 4, 11 ml) in autoimmune thyroiditis and 6 ml (IQR 3, 8 ml) in benign goitre post surgery. The weight

Open access

Norra Kwong, Ellen Marqusee, Michael S Gordon, P Reed Larsen, Jeffrey R Garber, Matthew I Kim, and Erik K Alexander

radioactive iodine (RAI) ( 131 I) ablation, followed by thyroid hormone suppression therapy (6, 7, 8, 9) . Though there may be benefits to this approach, especially for patients with advanced disease, increasing evidence confirms that such a standardized

Open access

Yun Hu, Na Li, Peng Jiang, Liang Cheng, Bo Ding, Xiao-Mei Liu, Ke He, Yun-Qing Zhu, Bing-li Liu, Xin Cao, Hong Zhou, and Xiao-Ming Mao

relationship between thyroid nodule and thyroid cancer ( 3 , 4 ). Thyroid nodules are usually accompanied by an increase in thyroglobulin (Tg) ( 5 , 6 ) and autoimmune thyroid diseases (AITDs), especially Hashimoto’s thyroiditis (HT) ( 7 , 8 ). Interestingly